Clik here to view.
Starbucks Redefines Partner (Employee) Benefits with a Critical Illness...
BEIJING Starbucks Coffee Company (NASDAQ: SBUX) today established a new precedent for the role and responsibility of a public company leading through the lens of humanity in China – its largest and...
View ArticleClik here to view.
Low-Level Light Therapy Accelerates Hair Growth in Chemotherapy Patients
BOCA RATON, Fla. Photobiomodulation therapy, or low-level light therapy (LLLT), has been shown to accelerate hair recovery by 2.6x in patients with chemotherapy-induced alopecia (CIA), according to...
View ArticleClik here to view.
Ansell Launches VivaGel® Condom in Canada
MELBOURNE, Australia Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) is pleased to announce the VivaGel® condom has been launched in Canada by Ansell (ASX:ANN) under the LifeStyles® Dual Protect™...
View ArticleClik here to view.
星巴克重新制定伙伴（员工）福利，为中国年迈父母提供重大疾病保险计划
北京 (美国商业资讯)–星巴克咖啡公司(Starbucks Coffee Company, NASDAQ:SBUX)今天通过在中国——星巴克最大、增长最快的第二市场——的人文关怀计划，为上市公司所应扮演的角色和肩负的责任树立了新的榜样。自2017年6月1日开始，星巴克将为公司在中国大陆各地运营的门店中符合资格的ii全职伙伴（员工）的父母i提供重大疾病保险计划。...
View ArticleClik here to view.
Second Sight’s Argus II Retinal Prosthesis Implanted in First Patient in Asia
SYLMAR, Calif. Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to...
View ArticleClik here to view.
Clik here to view.
PSMF邀请国际患者安全界参加2017年7月13日召开的该基金会第5届年中规划年会
加州尔湾 (美国商业资讯) — 患者安全运动基金会(PSMF)邀请来自全世界的患者安全专家、医护提供者、医院管理者、患者维权人士和政策制订者，来讨论挑战、头脑风暴解决方案和规划下一步，以达到在2020年之前将可预防死亡例数降至零的目标。与上次年中规划会议一样，本次会议主要是一次工作会议，旨在确定明年的目标。本次会议仅接受受邀者参加，将与Inova心血管研究所共同举办，地点在弗吉尼亚州Falls...
View ArticleClik here to view.
ファインデックス、AOSモバイルのアプリとの連携により緊急時画像参照ソリューションを強化
東京 （ビジネスワイヤ） — 株式会社ファインデックス（東証一部：3649 本社：東京 代表取締役：相原輝夫、以下ファインデックス）は、汎用画像診断用閲覧システム「ProRad Web ※2」とAOSモバイル株式会社（本社：東京 代表取締役：原田...
View ArticleClik here to view.
Shionogi presents New Data on Cefiderocol (S-649266), a Siderophore...
OSAKA, Japan Shionogi & Co., Ltd. today announced it will be presenting new data on cefiderocol (S-649266), an investigational siderophore cephalosporin in late stage development with activity...
View ArticleClik here to view.
Patent-Protected Indirect Bonding Techniques from 3M Oral Care
ST. PAUL‚ Minn. As thousands of orthodontists and staff from around the world descend on the Annual Session of the American Association of Orthodontists in San Diego, CA this week, 3M is proud to...
View ArticleClik here to view.
Simulations Plus Establishes Distribution Channel in India with Electrolab
LANCASTER, Calif. Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals...
View ArticleClik here to view.
EOS imaging Announces Opening of First Two EOS® Systems in China
PARIS EOS imaging (Paris:EOSI)(Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced the first two installations of EOS systems in China at Nanjing Drum...
View ArticleClik here to view.
AtriCure’s AtriClip System Surpasses 100,000 Units Sold Worldwide
MASON, Ohio AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced it has sold more than...
View ArticleClik here to view.
Astellas Reports Full Year FY2016 Financial Results
TOKYO Astellas Pharma Inc. (TOKYO:4503)(President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced the financial results for fiscal year 2016 (“FY2016”) ended March 31, 2017. “We achieved...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Ezetimibe and Simvastatin...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10...
View ArticleClik here to view.
CBRE Group, Inc. Acquires Leading Australian Healthcare Project Advisory and...
LOS ANGELES CBRE Group, Inc. (NYSE:CBG) today announced that it has acquired Aurora Projects Pty Limited (Aurora), a leading project advisory and management company in Australia. The acquisition...
View ArticleClik here to view.
Otsuka and Lundbeck Announce Results of Brexpiprazole on Symptoms of...
TOKYO Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announce top-line results from two phase III clinical trials evaluating the efficacy, safety and tolerability of...
View ArticleClik here to view.
Nanotherapeutics Bohumil s.r.o. and Praha Vaccines a.s. Finalize Transfer of...
ALACHUA, Fla. & PUNE, India Nanotherapeutics Bohumil s.r.o. (a wholly owned subsidiary of Nanotherapeutics, Inc.) and Cyrus Poonawalla Group announced today the final transfer of...
View ArticleClik here to view.
GI Dynamics Announces EndoBarrier Data to be Presented at Digestive Disease Week
BOSTON & SYDNEY GI Dynamics®, Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe, the Middle East and South America for patients with type 2 diabetes and...
View ArticleClik here to view.
アサーシスが大量細胞融解装置ThawSTARを臨床試験で使用するためにメドシジョンと提携
米カリフォルニア州サンラファエル （ビジネスワイヤ） — 凍結細胞融解の自動化における世界的リーダー企業メドシジョンと臨床段階のバイオテクノロジー企業として専有的な細胞療法製品を開発しているアサーシスは、アサーシスの臨床試験における凍結細胞融解装置ThawSTAR®（ソースター）の使用を含め、戦略的提携関係を構築しました。 提携の第一段階として、アサーシスは6 mL AT-Closed...
View Article